Sumatriptan Injection, Solution
Product Images NDC 55150-173

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 55150-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Time To Relief Of Cluster Headache From Time Of Injectiona (Sumatriptan Fig1)

Estimated percentage of subjects with relief after 20 and 25 minutes compared between Placebo (N=127) and Sumatriptan Injection (N=131).*

FDA Label Image

Package Label-principal Display Panel (6 mg/0.5 mL)

This text provides information about a medication called Sumatriptan, which is manufactured in India for Eugia US LLC. It is an injection containing 6 mg per 0.5 mL of the active ingredient. The medication is intended for subcutaneous injection only.*

FDA Label Image

Package Label-principal Display Panel (6 mg/0.5 mL)

This text provides information about Sumatriptan Injection USP in single-dose vials. Each vial contains 6 mg per 0.5 mL of the medication, intended for subcutaneous injection. The product is distributed by Eugia US LLC and has a specific NDC code. It is important for pharmacists to dispense with patient information and discard any unused portion. This medication is made in India and the code for the drug is TS/DRUGS/13/2010.*

FDA Label Image

Sumatriptan Chemical Structure (Sumatriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.